Maria Fardis - 09 Jun 2022 Form 3 Insider Report for CRISPR Therapeutics AG (CRSP)

Role
Director
Signature
/s/ Elizabeth Ryland Waldinger
Issuer symbol
CRSP
Transactions as of
09 Jun 2022
Net transactions value
$0
Form type
3
Filing time
10 Jun 2022, 17:33:35 UTC
Next filing
09 Jun 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney